Stocktoria
NEXGEL, INC. NXGL
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-22
NEXGEL, INC. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M | $8.7M | $4.1M | $2.0M | $1.6M | $674,000 | $717,000 | $2.2M |
| Gross profit | $4.5M | $2.7M | $374,000 | $256,000 | $8,000 | -$291,000 | -$137,000 | $514,000 |
| R&D expense | $2,000 | $78,000 | $103,000 | $367,000 | $31,000 | — | — | — |
| SG&A expense | $7.9M | $6.2M | $3.7M | $3.2M | $2.5M | $2.0M | $1.8M | $2.4M |
| Operating income | -$3.4M | -$3.6M | -$3.5M | -$3.3M | -$2.6M | -$2.3M | -$1.9M | -$1.9M |
| Interest expense | — | — | $15,000 | $1.3M | — | — | — | — |
| Income tax | — | — | — | $0 | $0 | $0 | $0 | — |
| Net income | -$3.0M | -$3.3M | -$3.2M | -$4.7M | -$4.3M | -$2.3M | -$1.9M | -$1.9M |
| EPS (diluted) | $-0.38 | $-0.50 | $-0.56 | $-0.85 | $-1.45 | $-1.05 | $-0.14 | $-0.38 |
| Operating cash flow | -$1.3M | -$3.9M | -$3.2M | -$3.0M | -$2.8M | -$1.8M | -$1.8M | -$1.5M |
| Free cash flow | -$1.4M | -$4.3M | -$3.9M | -$3.1M | -$3.0M | -$2.1M | -$1.8M | — |
| Cash & equivalents | — | $1.8M | $2.7M | — | $13.3M | $32,000 | $261,000 | $0 |
| Inventory | $2.1M | $1.8M | $1.3M | $502,000 | $291,000 | $233,000 | $113,000 | $101,000 |
| Total assets | $10.5M | $11.0M | $10.0M | $10.4M | $17.0M | $2.3M | $1.9M | $739,000 |
| Total liabilities | $5.6M | $4.9M | $4.8M | $2.7M | $4.9M | $2.2M | $1.5M | $458,000 |
| Shareholders' equity | $4.9M | $6.1M | $5.2M | $7.6M | $12.1M | $71,000 | $380,000 | $281,000 |
Growth · year-over-year · Revenue CAGR 26.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +31.5% | +112.5% | +99.7% | +32.0% | +130.1% | -6.0% | -67.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.